Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular basis of the VHL hereditary cancer syndrome
Kaelin, W. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc885 · Cited by 865
Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease
Jonasch, E., Donskov, F., Iliopoulos, O., Rathmell, W. K., Narayan, V. K., Maughan, B. L., Oudard, S., Else, T., Maranchie, J. K., Welsh, S. J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2103425 · Cited by 714
Multidisciplinary Team Working in Cancer: What Is the Evidence?
Taylor, C., Munro, A. J., Glynne-Jones, R., Griffith, C., Trevatt, P., Richards, M., & Ramirez, A. J. (2010) · BMJ · doi:10.1136/bmj.c951 · Cited by 473
Research works printed but not linked: 53
- Lonser, 2003, von Hippel-Lindau disease, Lancet, 361, 2059, 10.1016/S0140-6736(03)13643-4 · DOI · Paper page
- Schmid, 2014, Management of von Hippel-Lindau disease: an interdisciplinary review, Oncol Res Treat, 37, 761, 10.1159/000369362 · DOI
- Latif, 1993, Identification of the von Hippel-Lindau disease tumor suppressor gene, Science, 260, 1317, 10.1126/science.8493574 · DOI · Paper page
- Maxwell, 1999, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis, Nature, 399, 271, 10.1038/20459 · DOI · Paper page
- Gossage, 2015, VHL, the story of a tumour suppressor gene, Nat Rev Cancer, 15, 55, 10.1038/nrc3844 · DOI · Paper page
- Arreola, 2018, Von Hippel-Lindau mutations disrupt vascular patterning and maturation via Notch, JCI Insight, 3, e92193, 10.1172/jci.insight.92193 · DOI
- Wiley, 2019, Management of retinal hemangioblastoma in von Hippel-Lindau disease, Retina, 39, 2254, 10.1097/IAE.0000000000002572 · DOI
- Wong, 2008, Retinal vascular proliferation as an ocular manifestation of von Hippel-Lindau disease, Arch Ophthalmol, 126, 637, 10.1001/archopht.126.5.637 · DOI
- Meyerle, 2008, Clinical course of retrobulbar hemangioblastomas in von Hippel-Lindau disease, Ophthalmology, 115, 1382, 10.1016/j.ophtha.2008.01.027 · doi:10.1016/j.ophtha.2008.01.027
- Stolle, 1998, Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene, Hum Mutat, 12, 417, 10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K · DOI · Paper page
- Hes, 2001, Clinical management of von Hippel-Lindau (VHL) disease, Neth J Med, 59, 225, 10.1016/S0300-2977(01)00165-6 · doi:10.1016/s0300-2977(01)00165-6
- Binderup, 2013, von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition, Dan Med J, 60, B4763:1
- Kruizinga, 2014, Calculating optimal surveillance for detection of von Hippel-Lindau-related manifestations, Endocr Relat Cancer, 21, 63, 10.1530/ERC-13-0308 · DOI
- Rednam, 2017, von Hippel-Lindau and hereditary pheochromocytoma/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood, Clin Cancer Res, 23, e68, 10.1158/1078-0432.CCR-17-0547 · DOI · Paper page
- Grubb, 2005, Management of von Hippel-Lindau-associated kidney cancer, Nat Clin Pract Urol, 2, 248, 10.1038/ncpuro0179 · DOI
- Stukalin, 2016, Contemporary treatment of metastatic renal cell carcinoma, Oncol Rev, 10, 295
- Binderup, 2017, Survival and causes of death in patients with von Hippel-Lindau disease, J Med Genet, 54, 11, 10.1136/jmedgenet-2016-104058 · DOI · Paper page
- Daniels, 2023, Guidelines for surveillance of patients with von Hippel-Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance, Cancer, 129, 2927, 10.1002/cncr.34896 · DOI · Paper page
- Shekelle, 1999, Clinical guidelines: developing guidelines, BMJ, 318, 593, 10.1136/bmj.318.7183.593 · DOI · Paper page
- Moore, 1991, Ophthalmological screening for von Hippel-Lindau disease, Eye (Lond), 5, 723, 10.1038/eye.1991.133 · doi:10.1038/eye.1991.133
- Maher, 1990, Clinical features and natural history of von Hippel-Lindau disease, Q J Med, 77, 1151
- Dollfus, 2002, Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study, Invest Ophthalmol Vis Sci, 43, 3067
- Kreusel, 2006, Retinal angiomatosis in von Hippel-Lindau disease: a longitudinal ophthalmologic study, Ophthalmology, 113, 1418, 10.1016/j.ophtha.2006.02.059 · doi:10.1016/j.ophtha.2006.02.059
- Wong, 2008, Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease, Ophthalmology, 115, 181, 10.1016/j.ophtha.2007.03.009 · doi:10.1016/j.ophtha.2007.03.009
- Feletti, 2016, von Hippel-Lindau disease: an evaluation of natural history and functional disability, Neuro Oncol, 18, 1011, 10.1093/neuonc/nov313 · DOI
- Binderup, 2018, Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease, Br J Ophthalmol, 102, 942, 10.1136/bjophthalmol-2017-310884 · DOI
- Launbjerg, 2017, von Hippel-Lindau development in children and adolescents, Am J Med Genet A, 173, 2381, 10.1002/ajmg.a.38324 · doi:10.1002/ajmg.a.38324
- Melmon, 1964, Lindau’s disease. Review of the literature and study of a large kindred, Am J Med, 36, 595, 10.1016/0002-9343(64)90107-X · doi:10.1016/0002-9343(64)90107-x
- Chahoud, 2021, Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease, World J Urol, 39, 2409, 10.1007/s00345-020-03441-3 · DOI
- Huntoon, 2021, Hemangioblastoma diagnosis and surveillance in von Hippel-Lindau disease: a consensus statement, J Neurosurg, 136, 1511, 10.3171/2021.3.JNS204203 · doi:10.3171/2021.3.jns204203
- Mehta, 2021, Endolymphatic sac tumor screening and diagnosis in von Hippel-Lindau disease: a consensus statement, J Neurol Surg B Skull Base, 83, e225
- Laks, 2022, Management recommendations for pancreatic manifestations of von Hippel-Lindau disease, Cancer, 128, 435, 10.1002/cncr.33978 · DOI · Paper page
- Singh, 2001, Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease, Ophthalmology, 108, 1907, 10.1016/S0161-6420(01)00758-8 · doi:10.1016/s0161-6420(01)00758-8
- Frantzen, 2012, Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau disease, Neurology, 79, 793, 10.1212/WNL.0b013e3182661f3c · doi:10.1212/wnl.0b013e3182661f3c
- Ye, 2012, Effect of pregnancy on hemangioblastoma development and progression in von Hippel-Lindau disease, J Neurosurg, 117, 818
- Binderup, 2015, New von Hippel-Lindau manifestations develop at the same or decreased rates in pregnancy, Neurology, 85, 1500, 10.1212/WNL.0000000000002064 · doi:10.1212/wnl.0000000000002064
- Othmane, 1999, Postpartum cerebellar herniation in von Hippel-Lindau syndrome, Am J Ophthalmol, 128, 387, 10.1016/S0002-9394(99)00199-3 · doi:10.1016/s0002-9394(99)00199-3
- Chen, 2018, Early detection of retinal hemangioblastomas in von Hippel-Lindau disease using ultra-widefield fluorescein angiography, Retina, 38, 748, 10.1097/IAE.0000000000001601 · doi:10.1097/iae.0000000000001601
- Rasmussen, 2010, Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease, BMC Med Genet, 11, 4, 10.1186/1471-2350-11-4 · doi:10.1186/1471-2350-11-4
- Lammens, 2011, Compliance with periodic surveillance for von-Hippel-Lindau disease, Genet Med, 13, 519, 10.1097/GIM.0b013e3182091a1d · DOI
- Wolters, 2022, Multidisciplinary integrated care pathway for von Hippel-Lindau disease, Cancer, 128, 2871, 10.1002/cncr.34265 · DOI · Paper page
- Taplin, 2015, Reviewing cancer care team effectiveness, J Oncol Pract, 11, 239, 10.1200/JOP.2014.003350 · DOI · Paper page
- Van Groenendael, 2015, High quality, patient centred and coordinated care for Alstrom syndrome: a model of care for an ultra-rare disease, Orphanet J Rare Dis, 10, 149, 10.1186/s13023-015-0366-y · doi:10.1186/s13023-015-0366-y
- von Kodolitsch, 2016, The role of the multidisciplinary health care team in the management of patients with Marfan syndrome, J Multidiscip Healthc, 9, 587, 10.2147/JMDH.S93680 · doi:10.2147/jmdh.s93680
- Auvin, 2019, A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report, Orphanet J Rare Dis, 14, 91, 10.1186/s13023-019-1072-y · DOI
- Gaudric, 2011, Vitreoretinal surgery for severe retinal capillary hemangiomas in von Hippel-Lindau disease, Ophthalmology, 118, 142, 10.1016/j.ophtha.2010.04.031 · DOI
- Krzystolik, 2016, Pars plana vitrectomy in advanced cases of von Hippel-Lindau eye disease, Retina, 36, 325, 10.1097/IAE.0000000000000707 · DOI
- Kreusel, 1998, Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma, Ophthalmology, 105, 1386, 10.1016/S0161-6420(98)98017-4 · doi:10.1016/s0161-6420(98)98017-4
- Raja, 2004, Salvage external beam radiotherapy of retinal capillary hemangiomas secondary to von Hippel-Lindau disease: visual and anatomic outcomes, Ophthalmology, 111, 150, 10.1016/j.ophtha.2003.04.003 · doi:10.1016/j.ophtha.2003.04.003
- Singh, 2002, Treatment of retinal capillary hemangioma, Ophthalmology, 109, 1799, 10.1016/S0161-6420(02)01177-6 · DOI · Paper page
- Krivosic, 2017, Laser photocoagulation for peripheral retinal capillary hemangioblastoma in von Hippel-Lindau disease, Ophthalmol Retina, 1, 59, 10.1016/j.oret.2016.08.004 · doi:10.1016/j.oret.2016.08.004
- 2021, FDA OK’s HIF2α inhibitor belzutifan, Cancer Discov, 11, 2360, 10.1158/2159-8290.CD-NB2021-0377 · DOI
- Aronow, 2019, von Hippel-Lindau Disease: update on pathogenesis and systemic aspects, Retina, 39, 2243, 10.1097/IAE.0000000000002555 · DOI
Metadata
- Authors
- Daniels, A. B., Chang, E. Y., Chew, E. Y., Gombos, D. S., Gorin, M. B., Shields, C. L., & Wiley, H. E.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2024-05
- Volume
- 131
- Issue
- 5
- Pages
- 622-633
- ISSN
- 0161-6420
- Cited by
- 26
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 352 d)
- Funders
- NEI (K08EY027464)
- National Institutes of Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease. https://app.cochat.ai/papers/10.1016/j.ophtha.2023.12.014
- The paper
- Daniels, A. B., Chang, E. Y., Chew, E. Y., Gombos, D. S., Gorin, M. B., Shields, C. L., & Wiley, H. E. (2024). Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease. Ophthalmology. https://doi.org/10.1016/j.ophtha.2023.12.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.